You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Climate Impact Visualization Tools Using Virtual 3D City for Community Based Planning and Outreach
SBC: Intelligent Automation, Inc. Topic: 931RCIntelligent Automation, Inc. proposes an innovative visualization tool that transforms online GIS mappers into a climate impact assessment and planning tool that allows planners to visualize the impact of storm surges with sea level rise and coastal erosion using a 3D virtual city. The goal is to assist planners and emergency services to adapt to climate change at three tiers: i) Tier 3 (Long-te ...
SBIR Phase I 2013 Department of CommerceNational Oceanic and Atmospheric Administration -
Humanized Monoclonal Antibodies to Treat Acinetobacter Infections
SBC: BIOLOGICAL ANTI-INFECTIVE MEDICINES, LLC Topic: NIAIDDESCRIPTION (provided by applicant): In the last decade, Acinetobacter baumannii has emerged as one of the most highly antibiotic-resistant pathogens in the United States (US) and throughout the world. These infections are increasingly prevalent and highlylethal, killing 50-60% of those infected. Worse, strains of A. baumannii that no known antibiotic will kill have now emerged, and will continue ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Immunotherapeutics to prevent HCV reinfection
SBC: Integrated Biotherapeutics, Inc. Topic: NIAIDDESCRIPTION (provided by applicant): Up to 170 million people worldwide are chronically infected with HCV Hepatitis C virus (HCV) putting the infected individuals at significant risk for cirrhosis, liver failure and liver cancer. End- stage liver diseasecaused by HCV is the leading indication of liver transplantation (LT) in the United States. However, reinfection with HCV occurs universally and ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Preparation and Characterization of 2nd Generation HIV-1 Maturation Inhibitor Dru
SBC: DFH Pharma, Inc Topic: NIAIDDESCRIPTION (provided by applicant): Despite advances in the development of HIV drugs there remains a need for new therapies. Toxicities associated with long term use of many of the approved HIV drugs coupled with the development of resistance drives the need for new and novel antivirals. Maturation inhibitors (MIs) represent one such class of HIV therapies. HIV maturation inhibitors block virus r ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Mobile App Targeting Meth Use, HIV Sex Risks and ART Adherence for Gay/Bisexual Men
SBC: COG ANALYTICS, LLC Topic: NIDADESCRIPTION (provided by applicant): Methamphetamine use among gay and bisexually identified men (GBM) and other men who have sex with men (MSM) is strongly associated with HIV infection due to the concomitant high-risk sexual behaviors that often occur while using the drug. As a result, HIV prevalence is significantly higher among MSM that report frequent use of methamphetamine and highest among ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Communication in Infants and Social Screener: The CISS
SBC: PAUL H BROOKES PUBLISHING CO., INC. Topic: NIDCDDESCRIPTION (provided by applicant): Effective early intervention depends on reliable screening of risk for communication impairments as soon as possible. Established infant communication risk factors include poor attention, gestures, social connectedness,exploratory play, and speech. Although these risk factors can be detected by 12-18 mos. and reliably predict later language and social disorders ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Non-invasive method to evaluate the quality of human oocytes and embryos
SBC: Renova Life Inc. Topic: NICHDDESCRIPTION (provided by applicant): Project Summary We propose to develop a non-invasive method to predict mammalian oocyte quality by analyzing the surrounding cumulus cells' gene expression patterns (cGEP). The result of the cGEP assay---a cGEP score---can be used to predict embryo quality and ultimately the embryo transfer (ET) results. This technology, if success, will for the first time ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Fluorescence Intensity-based Scoring of Macromolecule Crystallization Plates
SBC: iXpressGenes, Inc. Topic: NIGMSDESCRIPTION (provided by applicant): Crystallization, followed by subsequent structure determination, is a major step in understanding the structure- function relationship of macromolecules. Understanding macromolecule structure has become a key part in the development of new pharmaceuticals, and is a major area of NIH research. Crystallization however is also the rate limiting step, despite techn ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Microfabricated Neural Probe for the Rapid Detection of Multiple Neurochemicals I
SBC: DIAGNOSTIC BIOCHIPS, INC Topic: NIAAADESCRIPTION (provided by applicant): The specific aim of this application is to test the feasibility of developing a long-lasting, implantable probe for rapid measurement of multiple neurochemicals in the brain. Currently, neuroscience research is limitedto three techniques for measuring the concentrations of neurochemicals in vivo; microdialysis to obtain average concentrations over a relatively ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Micro_patterned Surfaces for Reducing the Risk of Ventilator_Associated Pneumonia
SBC: SANARIA INC. Topic: NIAIDDESCRIPTION (provided by applicant): A highly effective vaccine that targets the asymptomatic sporozoite (SPZ) and liver stages of the most lethal human malaria parasite, Plasmodium falciparum (Pf), would be an ideal tool to prevent malaria infection, disease and transmission. After 3 decades of effort, the most effective subunit malaria vaccine only provides 50% protection against infection at 2 ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health